Literature DB >> 16277544

Reporting pharmacoeconomic evaluations.

C I Carswell, J A Paladino.   

Abstract

Mesh：

Year:  2005        PMID： 16277544     DOI： 10.2165/00019053-200523110-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  9 in total

1.  Pharmacoeconomic analyses: making them transparent, making them credible.

Authors:  D Rennie; H S Luft
Journal:  JAMA       Date:  2000-04-26       Impact factor: 56.272

Review 2.  Decision analytic modelling in the economic evaluation of health technologies. A consensus statement. Consensus Conference on Guidelines on Economic Modelling in Health Technology Assessment.

Authors: 
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 3.  Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine.

Authors:  J E Siegel; G W Torrance; L B Russell; B R Luce; M C Weinstein; M R Gold
Journal:  Pharmacoeconomics       Date:  1997-02       Impact factor: 4.981

4.  New BMJ policy on economic evaluations.

Authors:  Richard Smith
Journal:  BMJ       Date:  2002-11-16

5.  Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

Authors:  Milton C Weinstein; Bernie O'Brien; John Hornberger; Joseph Jackson; Magnus Johannesson; Chris McCabe; Bryan R Luce
Journal:  Value Health       Date:  2003 Jan-Feb       Impact factor: 5.725

Review 6.  Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making.

Authors:  Michael Drummond; Ruth Brown; A Mark Fendrick; Pete Fullerton; Peter Neumann; Rod Taylor; Marco Barbieri
Journal:  Value Health       Date:  2003 Jul-Aug       Impact factor: 5.725

7.  Transparency in economic evaluations.

Authors:  Suzanne Hill
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

8.  Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet.

Authors:  T Jefferson; R Smith; Y Yee; M Drummond; M Pratt; R Gale
Journal:  JAMA       Date:  1998-07-15       Impact factor: 56.272

9.  Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Authors:  M F Drummond; T O Jefferson
Journal:  BMJ       Date:  1996-08-03
  9 in total
  1 in total

1.  Meandering down the road to transparency.

Authors:  Christopher I Carswell; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.